Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL95210 | 0.87 | TSHR (0.42) | CYP3A4TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL2053017 | 0.83 | TSHR (0.38) | CYP3A4TSHRALDH1A1TDP1CYP1A2 | |
| SCHEMBL8098752 | 0.83 | JAK2 (0.31) | — | |
| SCHEMBL2045858 | 0.83 | CES2 (0.34) | ALDH1A1 | |
| SCHEMBL103338 | 0.81 | — | — | |
| SCHEMBL4758532 | 0.78 | LMNA (0.40) | CYP3A4TSHRALDH1A1KMT2ACYP1A2 | |
| SCHEMBL6210902 | 0.78 | CA12 (0.41) | CYP3A4MEN1ALDH1A1KMT2A | |
| SCHEMBL11393405 | 0.78 | CYP2A6 (0.45) | ALDH1A1TDP1CYP1A2CYP2A6 | |
| SCHEMBL2515771 | 0.78 | P2RX7 (0.44) | — | |
| SCHEMBL5222485 | 0.76 | TDP1 (0.47) | TSHRMEN1ALDH1A1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371616-B2 | Laminate and production method thereof | KONICA MINOLTA HOLDINGS, INC. (JP) | 2016-06-21 | — | — | US | disclosed |
| EP-2426102-A1 | PROCESS FOR PRODUCING PHTHALIC ACID COMPOUND INCLUDING CHLORINATED AROMATIC RING | Sumitomo Chemical Company, Limited (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-20120035395-A1 | PROCESS FOR PRODUCING PHTHALIC ACID COMPOUND INCLUDING CHLORINATED AROMATIC RING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20100173146-A1 | LAMINATE AND PRODUCTION METHOD THEREOF | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-07-08 | — | — | US | disclosed |
| US-5801230-A | Polyfunctional azo reactive dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1998-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035395-A1 | PROCESS FOR PRODUCING PHTHALIC ACID COMPOUND INCLUDING CHLORINATED AROMATIC RING | NISCH, DDT, CUL1 | CYP3A4 494/4885TSHR 82/4885MEN1 1575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.